Biotricity, Inc.BTCYNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P27
Within normal range
vs 5Y Ago
-3.9x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | -16.18% |
| 2024 | -20.37% |
| 2023 | 17.68% |
| 2022 | 33.29% |
| 2021 | 51.05% |
| 2020 | 4.13% |
| 2019 | -25.72% |
| 2018 | 54.85% |
| 2017 | -0.45% |
| 2016 | 4828.68% |